hematoxylin has been researched along with hoe 33342 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, S; Araki-Sasaki, K; Shimomura, N; Yamagami, S; Yokoo, S | 1 |
| Liu, XY; Qian, QJ; Wang, YG; Yang, M; Yu, DB; Zheng, S; Zhong, SY | 1 |
2 other study(ies) available for hematoxylin and hoe 33342
| Article | Year |
|---|---|
Decellularizing corneal stroma using N2 gas.
Topics: Animals; Anterior Eye Segment; Benzimidazoles; Cell Nucleus; Corneal Stroma; Corneal Transplantation; Eosine Yellowish-(YS); Hematoxylin; In Situ Nick-End Labeling; Nitrogen; Rabbits; Swine; Time Factors | 2008 |
Potent antitumor activity of double-regulated oncolytic adenovirus-mediated ST13 for colorectal cancer.
Topics: Adenoviridae; Animals; Apoptosis; Benzimidazoles; Cell Death; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Coloring Agents; Cytopathogenic Effect, Viral; Eosine Yellowish-(YS); Female; Fluorescent Dyes; Gene Expression; Genetic Therapy; Genetic Vectors; Gentian Violet; HCT116 Cells; Hematoxylin; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Nude; Oncolytic Virotherapy; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2009 |